Pulmonary embolism is a medical emergency that occurs when a blood clot in the deep veins of the legs or pelvis travels to the lungs and blocks blood flow. In situ thrombolysis and thrombectomy are two treatment options for pulmonary embolism.
In situ thrombolysis involves the use of medications, such as tissue plasminogen activator (tPA), to dissolve the blood clot directly in the lungs. The medications are typically administered through a catheter that is inserted through a vein in the leg or neck and guided to the site of the clot in the lung. The medications are then delivered directly to the clot to break it up and restore blood flow.
Thrombectomy is a surgical procedure that involves removing the blood clot from the lungs using a catheter. The catheter is inserted through a vein in the leg or neck and guided to the site of the clot in the lung. A special tool is then used to break up and remove the clot, restoring blood flow.
Both in situ thrombolysis and thrombectomy are effective treatment options for pulmonary embolism, and the choice of treatment depends on the severity of the condition and the patient’s overall health. The procedures are typically performed in a hospital setting under sedation or general anesthesia.